156 filings
8-K
ARCT
Arcturus Therapeutics Holdings Inc
8 May 24
Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress
4:05pm
DEF 14A
ARCT
Arcturus Therapeutics Holdings Inc
Definitive proxy
29 Apr 24
4:05pm
8-K
ARCT
Arcturus Therapeutics Holdings Inc
5 Apr 24
Changes in Registrant's Certifying Accountant
5:00pm
8-K
ARCT
Arcturus Therapeutics Holdings Inc
19 Mar 24
Regulation FD Disclosure
6:00am
8-K/A
5wit7f nr
14 Mar 24
Results of Operations and Financial Condition
9:05am
8-K
2vcweuq922
7 Mar 24
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress
4:05pm
8-K
0ot6b90zhw3bpmm pw0p
23 Feb 24
Departure of Directors or Certain Officers
4:05pm
8-K
pje4jo
14 Nov 23
Arcturus Therapeutics Announces Third Quarter 2023 Financial Update
4:10pm
8-K
u1rlsfozhm9w9nmw0wb5
26 Sep 23
Entry into a Material Definitive Agreement
4:06pm
8-K
zdvzky1
14 Aug 23
Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded $115 Million in Grants from the Japanese Government
12:00am
8-K
3nvnijxm1u6a2
7 Aug 23
Arcturus Therapeutics Announces Second Quarter 2023 Financial Update and Pipeline Progress
4:23pm
424B5
dazas4
7 Aug 23
Prospectus supplement for primary offering
4:20pm
8-K
nl8c 1x6s4bxwtq
14 Jul 23
Regulation FD Disclosure
7:53am
8-K
2a1cj63quxa
30 Jun 23
Regulation FD Disclosure
8:28am
8-K
w3tvws5sy
16 Jun 23
Submission of Matters to a Vote of Security Holders
4:32pm